Full Article

Hong Kong J Radiol 2010;13(Suppl):S3-9

J Cassidy

Colorectal cancer is one of the most frequently diagnosed malignancies in the world. In spite of recent advances in chemotherapy, the prognosis for patients with metastatic colorectal cancer remains poor. The last decade of ground-breaking research on molecular

Full Article

VHF Lee

Hong Kong J Radiol 2010;13(Suppl):S16-21

Systemic chemotherapy has been the standard treatment for advanced / metastatic non–small-cell lung cancer, particularly in those who do not harbour an epidermal growth factor receptor mutation. In the last decade, there was no established evidence to justify

Full Article

W Yeo

Hong Kong J Radiol 2010;13(Suppl):S25-8

Gastric cancer is the fourth commonest cancer worldwide, with nearly a million new patients being diagnosed with this disease per year, of whom 55% are in East Asia. Regrettably, despite the availability of potentially curative resection, between 50 and 90% of

Full Article

RKC Ngan

Hong Kong J Radiol 2010;13(Suppl):S33-41

The GOG111 and OV-10 were pivotal studies published in 1996 and 2000 respectively which established paclitaxel / cisplatin as standard postoperative adjuvant chemotherapy for advanced epithelial ovarian cancers. A second major breakthrough in the ensuing